rs543886209

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001006658.3(CR2):​c.389T>C​(p.Val130Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,611,190 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000079 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 3 hom. )

Consequence

CR2
NM_001006658.3 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.938

Publications

0 publications found
Variant links:
Genes affected
CR2 (HGNC:2336): (complement C3d receptor 2) This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
CR2 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025568426).
BP6
Variant 1-207466856-T-C is Benign according to our data. Variant chr1-207466856-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 540315.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000788 (12/152268) while in subpopulation SAS AF = 0.00228 (11/4822). AF 95% confidence interval is 0.00128. There are 1 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 Unknown,AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CR2NM_001006658.3 linkc.389T>C p.Val130Ala missense_variant Exon 2 of 20 ENST00000367057.8 NP_001006659.1 P20023-3
CR2NM_001877.5 linkc.389T>C p.Val130Ala missense_variant Exon 2 of 19 NP_001868.2 P20023-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CR2ENST00000367057.8 linkc.389T>C p.Val130Ala missense_variant Exon 2 of 20 1 NM_001006658.3 ENSP00000356024.3 P20023-3

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152150
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000261
AC:
65
AN:
249096
AF XY:
0.000386
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000122
AC:
178
AN:
1458922
Hom.:
3
Cov.:
32
AF XY:
0.000183
AC XY:
133
AN XY:
725612
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33214
American (AMR)
AF:
0.00
AC:
0
AN:
44178
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25916
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.00191
AC:
164
AN:
85890
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.00000810
AC:
9
AN:
1110718
Other (OTH)
AF:
0.0000830
AC:
5
AN:
60222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152268
Hom.:
1
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41552
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000734
Hom.:
0
Bravo
AF:
0.0000151
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000354
AC:
43
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 06, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.389T>C (p.V130A) alteration is located in exon 2 (coding exon 2) of the CR2 gene. This alteration results from a T to C substitution at nucleotide position 389, causing the valine (V) at amino acid position 130 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Immunodeficiency, common variable, 7 Benign:1
Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
T;.;.
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.041
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.62
T;T;T
M_CAP
Benign
0.032
D
MetaRNN
Benign
0.026
T;T;T
MetaSVM
Benign
-0.68
T
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
0.94
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-2.1
N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.063
T;D;T
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
0.41
B;B;P
Vest4
0.28
MutPred
0.80
Gain of ubiquitination at K128 (P = 0.044);Gain of ubiquitination at K128 (P = 0.044);Gain of ubiquitination at K128 (P = 0.044);
MVP
0.73
MPC
0.27
ClinPred
0.039
T
GERP RS
5.0
Varity_R
0.29
gMVP
0.41
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs543886209; hg19: chr1-207640201; API